- Home
- AWX vs KZIA Comparison
AWX vs KZIA Comparison
Compare AWX & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWX
- KZIA
- Stock Information
- Founded
- AWX 1998
- KZIA 1994
- Country
- AWX United States
- KZIA Australia
- Employees
- AWX N/A
- KZIA N/A
- Industry
- AWX Environmental Services
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- AWX Utilities
- KZIA Health Care
- Exchange
- AWX Nasdaq
- KZIA Nasdaq
- Market Cap
- AWX 9.7M
- KZIA 11.7M
- IPO Year
- AWX 1998
- KZIA 1999
- Fundamental
- Price
- AWX $2.51
- KZIA $8.17
- Analyst Decision
- AWX
- KZIA Strong Buy
- Analyst Count
- AWX 0
- KZIA 2
- Target Price
- AWX N/A
- KZIA $14.00
- AVG Volume (30 Days)
- AWX 5.2K
- KZIA 75.5K
- Earning Date
- AWX 08-08-2025
- KZIA 08-19-2025
- Dividend Yield
- AWX N/A
- KZIA N/A
- EPS Growth
- AWX 686.28
- KZIA N/A
- EPS
- AWX 0.03
- KZIA N/A
- Revenue
- AWX $78,200,000.00
- KZIA $1,549,158.00
- Revenue This Year
- AWX N/A
- KZIA N/A
- Revenue Next Year
- AWX N/A
- KZIA $49.25
- P/E Ratio
- AWX $82.96
- KZIA N/A
- Revenue Growth
- AWX N/A
- KZIA 248983.08
- 52 Week Low
- AWX $2.10
- KZIA $2.86
- 52 Week High
- AWX $3.99
- KZIA $39.05
- Technical
- Relative Strength Index (RSI)
- AWX 43.59
- KZIA 46.19
- Support Level
- AWX $2.51
- KZIA $7.40
- Resistance Level
- AWX $2.65
- KZIA $8.99
- Average True Range (ATR)
- AWX 0.04
- KZIA 0.64
- MACD
- AWX -0.01
- KZIA -0.23
- Stochastic Oscillator
- AWX 0.26
- KZIA 25.93
About AWX Avalon Holdings Corporation
Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.